BioTime, Inc.
BioTime Plans Warrant Distribution to Shareholders
Published in Blood Weekly, December 23rd, 2010
2010 DEC 23 -- BioTime, Inc. (NYSE Amex: BTX) announced that it plans to distribute new common share purchase warrants to the holders of BioTime common shares. Under the plan, shareholders will receive one warrant for every eight shares held. Each warrant will entitle the holder to purchase one common share for $12.00 per share. The warrants will expire four years after the date of issue. BioTime's Board of Directors has not yet set a record date for determining shareholders entitled to receive the warrants. The warrants will be freely tradable, and BioTime plans to apply to list the warrants on the NYSE Amex.
BioTime expects the pharmaceutical industry and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-12-23)
More Articles from Blood Weekly
- Diet and Nutrition
Scientists at University of Sao Paulo publish new data on diet and nutrition - Oncology
Data on oncology detailed by researchers at University of Florida, Department of Biomedical Engineering - Transplantation
Data on transplantation discussed by researchers at Harvard University - Blood Safety
Fidelity Janitorial has adopts emPower eLearning Solutions Bloodborne Pathogens Standard Online Course. - Cardiac Surgical Procedures
Findings from G. Bruschi and co-authors provide new insights into cardiac surgical procedures - Stem Cell Research
GeneCell International Opens Miami-Based Headquarters, First and Only Cord Blood Processing and Cryogenic Storage Laboratory in Miami - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
